Table 5 Outcomes in dCBT versus sCBT according to cell dose in multivariate analyses (adjusted for patient age, disease status, ALL versus AML, conditioning regimen, cytogenetic risk, and ATG)

sCBT and TNC > median (ref)

–

–

–

–

dCBT and TNC > median

1.32

0.67

2.58

0.42

sCBT and TNC < median

1.99

1.02

3.89

0.04

dCBT and TNC < median

1.74

0.88

3.43

0.11

sCBT and TNC > median (ref)

–

–

–

–

dCBT and TNC > median

0.69

0.35

1.36

0.29

sCBT and TNC < median

1.01

0.53

1.93

0.97

dCBT and TNC < median

0.93

0.47

1.83

0.84

sCBT and TNC > median (ref)

–

–

–

–

dCBT and TNC > median

0.97

0.61

1.55

0.89

sCBT and TNC < median

1.46

0.92

2.30

0.11

dCBT and TNC < median

1.27

0.79

2.03

0.33

sCBT and TNC > median (ref)

–

–

–

–

dCBT and TNC > median

0.97

0.60

1.58

0.91

sCBT and TNC < median

1.39

0.86

2.23

0.18

dCBT and TNC < median

1.07

0.65

1.77

0.78